Karuna Therapeutics, Inc.
KRTXDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771917
Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Karuna Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 195 | 1 | 256 | +62 |
| Shares | 29.9M | 740 | 34.0M | +4.16M (+13.9%) |
| Value | $3.77B | $93.6K | $7.65B | +$3.88B (+102.9%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (85)
Institutions that held Karuna Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (23)
Institutions that held Karuna Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Great Point Partners LLC | 149,000 | $18.9M |
| Ikarian Capital, LLC | 100,000 | $12.7M |
| Casdin Capital, LLC | 85,000 | $10.8M |
| Balyasny Asset Management LLC | 72,802 | $9.21M |
| Baker Bros. Advisors LP | 69,966 | $8.85M |
| Impax Asset Management Group plc | 49,463 | $6.26M |
| Affinity Asset Advisors, LLC | 45,000 | $5.69M |
| Pura Vida Investments, LLC | 29,900 | $3.78M |
| First Manhattan Co | 21,510 | $2.72M |
| MPM Oncology Impact Management LP | 20,000 | $2.53M |
| Boothbay Fund Management, LLC | 14,294 | $1.81M |
| Group One Trading, L.P. | 12,655 | $1.60M |
| Allianz Asset Management GmbH | 10,730 | $1.36M |
| DLD Asset Management, LP | 10,000 | $1.26M |
| ExodusPoint Capital Management, LP | 7,368 | $932.0K |
| CSS LLC | 5,676 | $718.0K |
| Worth Venture Partners, LLC | 4,800 | $640.0K |
| Janus Henderson Group PLC | 3,898 | $493.0K |
| Winton Group Ltd | 3,719 | $470.0K |
| Cornerstone Wealth Management, LLC | 1,805 | $228.0K |
| Federated Hermes, Inc. | 1,083 | $137.0K |
| International Biotechnology Trust PLC | 1,567 | $12.4K |
| Captrust Financial Advisors | 82 | $10.0K |
Not filed for Q3 2022 yet (1)
Institutions that held Karuna Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 740 | $93.6K |